Brief: AccuStem Sciences And EmeritusDX Announce Partnership To Commercialize MSC Test For Lung Cancer Screening
28/04/2025 12:26
April 28 (Reuters) - AccuStem Sciences Inc ACUT.PK: ACCUSTEM SCIENCES, INC. AND EMERITUSDX ANNOUNCE PARTNERSHIP TO COMMERCIALIZE MSC TEST FOR LUNG CANCER SCREENING Source text: ID:nGNX9DSQZH Further company coverage: ACUT.PK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on ACCUSTEM SCIENCES
See all newsBrief: AccuStem Sciences And EmeritusDX Announce Partnership To Commercialize MSC Test For Lung Cancer Screening
Brief: Accustem Sciences, Inc. Signs Agreement To Access Blood Samples From Lung Cancer Screening Trial To Expedite Msc Commercialization Plan
Brief: Accustem Sciences, Inc. And Emeritusdx Announce Joint Product Development Agreement And Strategic Partnership
Brief: Accustem Sciences Ltd Applies To List Common Stock On Nasdaq Under Symbol “ACUT” - SEC Filing